계산
총 자산 회전율 | = | 물품 판매1 | ÷ | 총 자산1 | |
---|---|---|---|---|---|
2024. 12. 31. | 0.35 | = | 32,026) | ÷ | 91,839) |
2023. 12. 31. | 0.28 | = | 26,910) | ÷ | 97,154) |
2022. 12. 31. | 0.38 | = | 24,801) | ÷ | 65,121) |
2021. 12. 31. | 0.40 | = | 24,297) | ÷ | 61,165) |
2020. 12. 31. | 0.39 | = | 24,240) | ÷ | 62,948) |
2019. 12. 31. | 0.37 | = | 22,204) | ÷ | 59,707) |
2018. 12. 31. | 0.34 | = | 22,533) | ÷ | 66,416) |
2017. 12. 31. | 0.27 | = | 21,795) | ÷ | 79,954) |
2016. 12. 31. | 0.28 | = | 21,892) | ÷ | 77,626) |
2015. 12. 31. | 0.29 | = | 20,944) | ÷ | 71,576) |
2014. 12. 31. | 0.28 | = | 19,327) | ÷ | 69,009) |
2013. 12. 31. | 0.28 | = | 18,192) | ÷ | 66,125) |
2012. 12. 31. | 0.31 | = | 16,639) | ÷ | 54,298) |
2011. 12. 31. | 0.31 | = | 15,295) | ÷ | 48,871) |
2010. 12. 31. | 0.34 | = | 14,660) | ÷ | 43,486) |
2009. 12. 31. | 0.36 | = | 14,351) | ÷ | 39,629) |
2008. 12. 31. | 0.40 | = | 14,687) | ÷ | 36,443) |
2007. 12. 31. | 0.41 | = | 14,311) | ÷ | 34,639) |
2006. 12. 31. | 0.41 | = | 13,858) | ÷ | 33,788) |
2005. 12. 31. | 0.41 | = | 12,022) | ÷ | 29,297) |
보고서 기준: 10-K (보고 날짜: 2024-12-31), 10-K (보고 날짜: 2023-12-31), 10-K (보고 날짜: 2022-12-31), 10-K (보고 날짜: 2021-12-31), 10-K (보고 날짜: 2020-12-31), 10-K (보고 날짜: 2019-12-31), 10-K (보고 날짜: 2018-12-31), 10-K (보고 날짜: 2017-12-31), 10-K (보고 날짜: 2016-12-31), 10-K (보고 날짜: 2015-12-31), 10-K (보고 날짜: 2014-12-31), 10-K (보고 날짜: 2013-12-31), 10-K (보고 날짜: 2012-12-31), 10-K (보고 날짜: 2011-12-31), 10-K (보고 날짜: 2010-12-31), 10-K (보고 날짜: 2009-12-31), 10-K (보고 날짜: 2008-12-31), 10-K (보고 날짜: 2007-12-31), 10-K (보고 날짜: 2006-12-31), 10-K (보고 날짜: 2005-12-31).
1 US$ 단위: 백만 달러
경쟁사와의 비교
Amgen Inc. | AbbVie Inc. | Bristol-Myers Squibb Co. | Danaher Corp. | Eli Lilly & Co. | Gilead Sciences Inc. | Johnson & Johnson | Merck & Co. Inc. | Pfizer Inc. | Regeneron Pharmaceuticals Inc. | Thermo Fisher Scientific Inc. | Vertex Pharmaceuticals Inc. | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
2024. 12. 31. | 0.35 | 0.42 | 0.52 | 0.31 | 0.57 | 0.48 | 0.49 | 0.55 | 0.30 | 0.38 | 0.44 | 0.49 |
2023. 12. 31. | 0.28 | 0.40 | 0.47 | 0.28 | 0.53 | 0.43 | 0.51 | 0.56 | 0.26 | 0.40 | 0.43 | 0.43 |
2022. 12. 31. | 0.38 | 0.42 | 0.48 | 0.37 | 0.58 | 0.43 | 0.51 | 0.54 | 0.51 | 0.42 | 0.46 | 0.49 |
2021. 12. 31. | 0.40 | 0.38 | 0.42 | 0.35 | 0.58 | 0.40 | 0.52 | 0.46 | 0.45 | 0.63 | 0.41 | 0.56 |
2020. 12. 31. | 0.39 | 0.30 | 0.36 | 0.29 | 0.53 | 0.36 | 0.47 | 0.52 | 0.28 | 0.50 | 0.47 | 0.53 |
2019. 12. 31. | 0.37 | 0.37 | 0.20 | 0.29 | 0.57 | 0.36 | 0.52 | 0.55 | 0.31 | 0.53 | 0.44 | 0.50 |
2018. 12. 31. | 0.34 | 0.55 | 0.64 | 0.42 | 0.56 | 0.34 | 0.53 | 0.51 | 0.34 | 0.57 | 0.43 | 0.49 |
2017. 12. 31. | 0.27 | 0.40 | 0.62 | 0.39 | 0.51 | 0.37 | 0.49 | 0.46 | 0.31 | 0.67 | 0.37 | 0.70 |
2016. 12. 31. | 0.28 | 0.39 | 0.58 | 0.37 | 0.55 | 0.53 | 0.51 | 0.42 | 0.31 | 0.70 | 0.40 | 0.59 |
2015. 12. 31. | 0.29 | 0.43 | 0.52 | 0.43 | 0.56 | 0.62 | 0.53 | 0.39 | 0.29 | 0.73 | 0.41 | 0.41 |
2014. 12. 31. | 0.28 | 0.72 | 0.47 | 0.54 | 0.53 | 0.71 | 0.57 | 0.43 | 0.29 | 0.73 | 0.39 | 0.25 |
2013. 12. 31. | 0.28 | 0.64 | 0.42 | 0.55 | 0.66 | 0.48 | 0.54 | 0.42 | 0.30 | 0.71 | 0.41 | 0.52 |
2012. 12. 31. | 0.31 | 0.68 | 0.49 | 0.55 | 0.66 | 0.44 | 0.55 | 0.45 | 0.32 | 0.66 | 0.46 | 0.55 |
2011. 12. 31. | 0.31 | — | 0.64 | 0.54 | 0.72 | 0.47 | 0.57 | 0.46 | 0.36 | 0.34 | 0.44 | 0.64 |
2010. 12. 31. | 0.34 | — | 0.63 | 0.59 | 0.74 | 0.64 | 0.60 | 0.43 | 0.35 | 0.42 | 0.51 | 0.08 |
2009. 12. 31. | 0.36 | — | 0.61 | 0.57 | 0.80 | 0.67 | 0.65 | 0.24 | 0.23 | 0.51 | 0.47 | 0.05 |
2008. 12. 31. | 0.40 | — | 0.70 | 0.73 | 0.70 | 0.72 | 0.75 | 0.51 | 0.43 | 0.36 | 0.50 | 0.18 |
2007. 12. 31. | 0.41 | — | 0.74 | 0.63 | 0.70 | 0.64 | 0.75 | 0.50 | 0.42 | 0.13 | 0.46 | 0.33 |
2006. 12. 31. | 0.41 | — | 0.70 | 0.75 | 0.71 | 0.63 | 0.76 | 0.51 | 0.42 | 0.11 | 0.18 | 0.23 |
2005. 12. 31. | 0.41 | — | 0.68 | 0.87 | 0.60 | 0.48 | 0.87 | 0.49 | 0.44 | 0.16 | 0.62 | 0.29 |
보고서 기준: 10-K (보고 날짜: 2024-12-31), 10-K (보고 날짜: 2023-12-31), 10-K (보고 날짜: 2022-12-31), 10-K (보고 날짜: 2021-12-31), 10-K (보고 날짜: 2020-12-31), 10-K (보고 날짜: 2019-12-31), 10-K (보고 날짜: 2018-12-31), 10-K (보고 날짜: 2017-12-31), 10-K (보고 날짜: 2016-12-31), 10-K (보고 날짜: 2015-12-31), 10-K (보고 날짜: 2014-12-31), 10-K (보고 날짜: 2013-12-31), 10-K (보고 날짜: 2012-12-31), 10-K (보고 날짜: 2011-12-31), 10-K (보고 날짜: 2010-12-31), 10-K (보고 날짜: 2009-12-31), 10-K (보고 날짜: 2008-12-31), 10-K (보고 날짜: 2007-12-31), 10-K (보고 날짜: 2006-12-31), 10-K (보고 날짜: 2005-12-31).
산업 부문과의 비교: 제약, 생명공학 및 생명과학
Amgen Inc. | 제약, 생명공학 및 생명과학 | |
---|---|---|
2024. 12. 31. | 0.35 | 0.43 |
2023. 12. 31. | 0.28 | 0.40 |
2022. 12. 31. | 0.38 | 0.47 |
2021. 12. 31. | 0.40 | 0.45 |
2020. 12. 31. | 0.39 | 0.39 |
2019. 12. 31. | 0.37 | 0.39 |
2018. 12. 31. | 0.34 | 0.45 |
2017. 12. 31. | 0.27 | 0.40 |
2016. 12. 31. | 0.28 | 0.41 |
2015. 12. 31. | 0.29 | 0.42 |
2014. 12. 31. | 0.28 | 0.44 |
2013. 12. 31. | 0.28 | 0.43 |
2012. 12. 31. | 0.31 | 0.45 |
2011. 12. 31. | 0.31 | 0.47 |
2010. 12. 31. | 0.34 | 0.47 |
2009. 12. 31. | 0.36 | 0.39 |
2008. 12. 31. | 0.40 | 0.57 |
2007. 12. 31. | 0.41 | 0.56 |
2006. 12. 31. | 0.41 | 0.54 |
2005. 12. 31. | 0.41 | 0.57 |
보고서 기준: 10-K (보고 날짜: 2024-12-31), 10-K (보고 날짜: 2023-12-31), 10-K (보고 날짜: 2022-12-31), 10-K (보고 날짜: 2021-12-31), 10-K (보고 날짜: 2020-12-31), 10-K (보고 날짜: 2019-12-31), 10-K (보고 날짜: 2018-12-31), 10-K (보고 날짜: 2017-12-31), 10-K (보고 날짜: 2016-12-31), 10-K (보고 날짜: 2015-12-31), 10-K (보고 날짜: 2014-12-31), 10-K (보고 날짜: 2013-12-31), 10-K (보고 날짜: 2012-12-31), 10-K (보고 날짜: 2011-12-31), 10-K (보고 날짜: 2010-12-31), 10-K (보고 날짜: 2009-12-31), 10-K (보고 날짜: 2008-12-31), 10-K (보고 날짜: 2007-12-31), 10-K (보고 날짜: 2006-12-31), 10-K (보고 날짜: 2005-12-31).
업계와의 비교: 의료
Amgen Inc. | 의료 | |
---|---|---|
2024. 12. 31. | 0.35 | 0.75 |
2023. 12. 31. | 0.28 | 0.73 |
2022. 12. 31. | 0.38 | 0.75 |
2021. 12. 31. | 0.40 | 0.70 |
2020. 12. 31. | 0.39 | 0.64 |
2019. 12. 31. | 0.37 | 0.65 |
2018. 12. 31. | 0.34 | 0.68 |
2017. 12. 31. | 0.27 | 0.66 |
2016. 12. 31. | 0.28 | 0.67 |
2015. 12. 31. | 0.29 | 0.64 |
2014. 12. 31. | 0.28 | 0.69 |
2013. 12. 31. | 0.28 | 0.67 |
2012. 12. 31. | 0.31 | 0.67 |
2011. 12. 31. | 0.31 | 0.69 |
2010. 12. 31. | 0.34 | 0.68 |
2009. 12. 31. | 0.36 | 0.63 |
2008. 12. 31. | 0.40 | 0.80 |
2007. 12. 31. | 0.41 | 0.77 |
2006. 12. 31. | 0.41 | 0.74 |
2005. 12. 31. | 0.41 | 0.72 |
보고서 기준: 10-K (보고 날짜: 2024-12-31), 10-K (보고 날짜: 2023-12-31), 10-K (보고 날짜: 2022-12-31), 10-K (보고 날짜: 2021-12-31), 10-K (보고 날짜: 2020-12-31), 10-K (보고 날짜: 2019-12-31), 10-K (보고 날짜: 2018-12-31), 10-K (보고 날짜: 2017-12-31), 10-K (보고 날짜: 2016-12-31), 10-K (보고 날짜: 2015-12-31), 10-K (보고 날짜: 2014-12-31), 10-K (보고 날짜: 2013-12-31), 10-K (보고 날짜: 2012-12-31), 10-K (보고 날짜: 2011-12-31), 10-K (보고 날짜: 2010-12-31), 10-K (보고 날짜: 2009-12-31), 10-K (보고 날짜: 2008-12-31), 10-K (보고 날짜: 2007-12-31), 10-K (보고 날짜: 2006-12-31), 10-K (보고 날짜: 2005-12-31).